SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

The highly transmissible Omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected in late 2021. Initial Omicron waves were primarily made up of sub-lineages BA.1 and/or BA.2, BA.4, and BA.5 subsequently became dominant in mid-2022, and several de...

Descripción completa

Detalles Bibliográficos
Autores principales: Pather, Shanti, Madhi, Shabir A., Cowling, Benjamin J., Moss, Paul, Kamil, Jeremy P., Ciesek, Sandra, Muik, Alexander, Türeci, Özlem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242031/
https://www.ncbi.nlm.nih.gov/pubmed/37287979
http://dx.doi.org/10.3389/fimmu.2023.1130539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242031/
https://www.ncbi.nlm.nih.gov/pubmed/37287979
http://dx.doi.org/10.3389/fimmu.2023.1130539

Ejemplares similares